IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,206 | -12.3% | 215,925 | +1.3% | 0.03% | -6.9% |
| Q2 2023 | $12,776 | +19.0% | 213,083 | -1.8% | 0.03% | +11.5% |
| Q1 2023 | $10,732 | -12.0% | 217,057 | +1.5% | 0.03% | -18.8% |
| Q4 2022 | $12,199 | -99.9% | 213,768 | +1.9% | 0.03% | +18.5% |
| Q3 2022 | $9,851,000 | -28.5% | 209,871 | -43.2% | 0.03% | -27.0% |
| Q2 2022 | $13,786,000 | +18.9% | 369,504 | -4.7% | 0.04% | +60.9% |
| Q1 2022 | $11,592,000 | -4.7% | 387,694 | +9.2% | 0.02% | 0.0% |
| Q4 2021 | $12,158,000 | -6.4% | 355,083 | +1.4% | 0.02% | -11.5% |
| Q3 2021 | $12,983,000 | -4.7% | 350,214 | +0.4% | 0.03% | -7.1% |
| Q2 2021 | $13,621,000 | -0.1% | 348,814 | +8.9% | 0.03% | -6.7% |
| Q1 2021 | $13,633,000 | – | 320,252 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |